Oligonucleotide Manufacturing Market - Likely Evolution of the Different Regions
by Roots Analysis Roots Analysis provides market research and consulSeveral industry players have established
oligonucleotide manufacturing facilities across the world. During our research,
we observed that a large number of companies have their manufacturing
facilities in North America and Europe.
Majority of oligonucleotide manufacturing
facilities have been established in the US alone. The high number of contract /
custom manufacturers in the US can be attributed to growing technical
expertise, and increased flow of foreign and domestic capital, which have
resulted in the establishment of state-of-the-art manufacturing facilities in
this region.
Moreover, manufacturers in these regions
have adopted various processes to comply with the stringent regulatory
standards and have received approval from regulatory authorities to carry out
both small and large-scale manufacturing on a contract basis. Examples of
manufacturers based in North America include (in alphabetical order)
ACGT, Ajinomoto Bio-Pharma Services, BianoGMP, Bridgen, Dharmacon, Medigene,
Quintara Biosciences, STA Pharmaceuticals and The Midland Certified Reagent
Company.
Following North America, several
manufacturing facilities were found to be located in Europe. Of these, majority
of the companies have their facilities location in Germany, UK, Sweden,
Switzerland, and Belgium.
Globalization and increased support from local governments
has driven numerous changes in domestic policies that favor outsourcing
opportunities in Asia-Pacific countries (such as India, China, South Korea,
Malaysia and Japan). It is worth highlighting that over
60% of the companies located in Asia-Pacific have been established in the last
two decades.
Furthermore, these companies are focused on
rapidly expanding their capabilities for manufacturing oligonucleotides amid
the increasing competition in this domain. Some of the well-established global and
/ or indigenous manufactures based in this region include (in alphabetical
order) Bioneer, GeneDesign, Hanugen Therapeutics,
Ruibo Biotechnology, ST Pharm, Sumitomo Chemical, Syngene, and Xcelris.
Complete report by Roots Analysis: Oligonucleotide
Synthesis, Modification and Purification Services Market: Focus on Research,
Diagnostic and Therapeutic Applications, 2020-2030
Sponsor Ads
Created on Jun 17th 2020 04:15. Viewed 295 times.